Savara Inc Live Stock Price Today, Share Analysis and Chart

Name: Savara Inc: Is Infosys Ltd. worth buying?
Item: Savara Inc
Rating: 1.45825
Author: Trendlyne DVM scores

about

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granul...

5.27 0.00 (0.00%)

178.84% Gain from 52W Low

1.3M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Savara Inc is on 19 May 2026 for the purpose of H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference See details

Not Eligible

Expensive Valuation

5.0 / 100

Technically Neutral

53.3 / 100

No estimates available

Savara Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Savara Inc Live Stock Price Today, Share Analysis and Chart

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granul...

178.84% Gain from 52W Low

SWOT Analysis

Savara Inc Live Price Chart